Guardian Pharmacy Services Inc (NYSE:GRDN)

Q3 2025 Guardian Pharmacy Services Inc Earnings Call Transcript

Nov 10, 2025 / 09:30 PM GMT

Release Date Price: $29.75 (+3.30%)

Transcript 10-Q8-K

Key Points

Positve

Guardian Pharmacy Services Inc (GRDN) reported a strong quarter with a 20% increase in revenue, reaching $377 million.
The company experienced a 13% growth in resident count, driven by both organic growth and acquisitions.
Adjusted EBITDA grew by 19% to $27 million, with margins holding steady at 7.2%.
The company raised its full-year revenue and adjusted EBITDA guidance, reflecting confidence in continued growth.
Guardian Pharmacy Services Inc (GRDN) has a strong acquisition pipeline and continues to expand its geographic footprint, particularly in the Pacific Northwest.

Negative

The Inflation Reduction Act presents ongoing challenges for the industry, impacting Guardian Pharmacy Services Inc (GRDN) and requiring advocacy for legislative solutions.
Recent acquisitions and greenfield startups have a dilutive impact on margins, with adjusted EBITDA margins down 10 basis points year over year.
The company faces potential headwinds from policy changes, particularly related to Medicare Part D and the broader healthcare environment.
There is a risk of flat reported revenue growth in 2026 due to policy and market conditions.
The company is still navigating the complexities of value-based models with payers, which is evolving at a slow pace.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GRDN.N - Guardian Pharmacy Services Inc
Q3 2025 Guardian Pharmacy Services Inc Earnings Call
Nov 10, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day everyone and welcome to Guardian Pharmacy's 3rd quarter earnings call.

At this time, all participants are on a listen-only mode.

Later you will have the opportunity to ask questions during the question-and-answer session.

I will now hand a call over to Ashley Stockton.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good afternoon.

Thank you for participating in today's conference call.

This is Ashley Stockton, senior director of investor relations for Guardian Pharmacy Services. I'm joined on today's

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.